新型神经保护剂BW619C89在自发性高血压大鼠和正常血压的Fischer 344大鼠局灶性缺血大脑中动脉闭塞模型中的评估。 - Suppr | 超能文献

Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat.

作者信息

Swan J H, Leach M J

机构信息

Division of Biology, Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.

出版信息

Ann N Y Acad Sci. 1995 Sep 15;765:39-46; discussion 59-61. doi: 10.1111/j.1749-6632.1995.tb16558.x.

DOI:10.1111/j.1749-6632.1995.tb16558.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat.新型神经保护剂BW619C89在自发性高血压大鼠和正常血压的Fischer 344大鼠局灶性缺血大脑中动脉闭塞模型中的评估。

Ann N Y Acad Sci. 1995 Sep 15;765:39-46; discussion 59-61. doi: 10.1111/j.1749-6632.1995.tb16558.x.

2

Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.BW619C89对大鼠大脑中动脉闭塞后神经功能缺损、认知功能缺损及脑损伤的长期有益作用。

Neuroscience. 1997 Apr;77(4):1123-35. doi: 10.1016/s0306-4522(96)00530-1.

3

Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat.BW619C89对大鼠局灶性或全脑缺血后的脑保护作用。

Neuroreport. 1993 Sep 30;4(12):1339-42. doi: 10.1097/00001756-199309150-00013.

4

Kynurenate does not reduce infarct size after middle cerebral artery occlusion in spontaneously hypertensive rats.犬尿喹啉酸不会减小自发性高血压大鼠大脑中动脉闭塞后的梗死面积。

Brain Res. 1990 Jun 4;518(1-2):353-5. doi: 10.1016/0006-8993(90)90997-p.

5

Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.谷氨酸释放抑制剂619C89对大脑中动脉短暂闭塞的神经保护作用

Brain Res. 1997 Feb 21;749(1):131-4. doi: 10.1016/s0006-8993(96)01311-x.

6

Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat.在大鼠局灶性脑缺血模型中，替加宾呈现剂量依赖性神经保护作用。

Neuroreport. 2000 Jul 14;11(10):2307-11. doi: 10.1097/00001756-200007140-00048.

7

Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat.在大鼠短暂性局灶性脑缺血模型中评估自由基在脑血管再灌注损伤中的作用。

Free Radic Biol Med. 1999 Mar;26(5-6):722-9. doi: 10.1016/s0891-5849(98)00257-3.

8

BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.BW619C89，一种谷氨酸释放抑制剂，可预防局灶性脑缺血损伤。

Stroke. 1993 Jul;24(7):1063-7. doi: 10.1161/01.str.24.7.1063.

9

Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.在大鼠短暂性局灶性脑缺血中，对电压依赖性钠离子通道拮抗剂BW619C89和电压依赖性钙离子通道拮抗剂尼莫地平进行平行剂量反应研究。

Eur J Pharmacol. 1999 Jan 8;364(2-3):99-105. doi: 10.1016/s0014-2999(98)00827-9.

10

Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.新型AMPA受体拮抗剂YM90K对大鼠局灶性脑缺血的神经保护作用

Brain Res. 1997 Oct 31;773(1-2):61-5. doi: 10.1016/s0006-8993(97)00894-9.

引用本文的文献

1

Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.可诱导型谷氨酸草酰乙酸转氨酶作为缺血性中风的治疗靶点。

Antioxid Redox Signal. 2015 Jan 10;22(2):175-86. doi: 10.1089/ars.2014.6106.

2

Trends and future developments in the pharmacological treatment of acute ischaemic stroke.急性缺血性脑卒中药物治疗的趋势与未来发展

Drugs. 1997 Jul;54(1):9-38. doi: 10.2165/00003495-199754010-00002.